Patent · US Active

Establishment and application of human immortalized B lymphocyte cell line group

US11643637B2 · kind B2 · utility

0Cited by
0References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 9, 2018
Grant dateMay 9, 2023
Priority date
Expiry dateJan 18, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12R2001/91
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present application provides a group of human immortalized B lymphocyte cell lines and use thereof, and specifically provides a combination of four closely related immortalized lymphocyte cell lines. The combination can be used as a reference substances for measuring the performance of a detection platform. When the four closely related immortalized lymphocyte cell lines are used as reference substances for epigenome, transcriptome, proteome, and metabolome, an intrinsic magnitude difference gradient can be formed to evaluate the sensitivity of histological detection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.